The European Research and Innovation Days (R&I Days) 2024 is the European Commission's annual flagship event, bringing together policymakers, researchers, entrepreneurs, and the public to debate and shape the future of research and innovation in Europe and beyond. This edition, taking place on March 20-21, offers a platform to discuss how Europe can become more sustainable and competitive while celebrating the remarkable outcomes achieved in research and innovation since the inception of the first R&I Framework Programme over 40 years ago. Attendees have the opportunity to explore successful EU-funded projects, experience their societal impact, and engage in debates on the continued investment in research and innovation. The agenda covers crucial topics such as Horizon Europe, the Strategic Plan 2025 – 2027, the Widening Instrument, R&I support for the Green and Digital transition, the Global Approach, and more. R&I Days 2024 provide an opportunity for participants to actively contribute to shaping the future of research and innovation.

As part of the Symposium, results from the first FDC study were presented by project partner University Medical Center of the Johannes Gutenberg University Mainz.

Dr. Christos Diou, of RELEVIUM partner Harokopio University, spoke on "AI in Healthcare" at Metropolitan Hospital, Athens, part of the Hellenic Healthcare Group. The talk also featured insights into the RELEVIUM project. Attendees included expert physicians from various specialties, alongside university professors from Athens School of Medicine.

The ASCO GI Cancers Symposium is the gateway to the latest advancements in GI cancer, offering innovative science, solution-focused strategies, and multidisciplinary approaches. It facilitates collaboration across specialties, featuring dedicated committees and faculty. Attendees can connect with global GI specialists, contribute to personalized cancer care progress, and explore 'Intersections'—new daily sessions providing multidisciplinary insights in 2024. Whether attending in person or virtually, participants can enjoy a versatile, interactive meeting with easy access to livestream sessions, polling, Q&A, and on-demand viewing of research presentations. The symposium provides an opportunity to stay updated on cutting-edge GI scientific research influencing immediate treatment decisions. With key learning objectives covering prevention, early diagnosis, breakthroughs in basic science, and clinical research, the ASCO GI Cancers Symposium is your gateway to the latest in oncological advancements.

The event will address the pressing challenges in European cancer care and discuss key priorities and effective strategies for the future. The summit emphasizes collaborative efforts to enhance cancer care in Europe. Co-chaired by Winette van der Graaf and Kathy Oliver, the program promises to be a comprehensive exploration of the present and future of cancer care in the region.

As part of the Symposium, results from the first FDC study were presented by project partner University Medical Center of the Johannes Gutenberg University Mainz.

The VITALISE consortium, together with ENoLL, will be holding an event entitled “Health and Wellbeing Living Lab Symposium,” which highlights the VITALISE project's achievements in harmonizing Living Lab services, emphasizing their role as integral Research Infrastructures. Through collaborative efforts over the past three years, the project has underscored the significance of Living Labs in driving global research. The event aims to facilitate discussions with the European Commission and stakeholders to shape the future of Research Infrastructures, promoting community involvement in co-research. Additionally, it provides a platform to showcase ongoing research conducted within Living Labs. AINIGMA, one of the partners of the RELEVIUM project involved in Product Development, will be participating in the symposium. They will be presenting their research on sarcopenia with the abstract “Sarcopenia detection with portable ultrasound,” which includes their affiliation with the RELEVIUM project and their role in sarcopenia estimation using AI tools.

As Pancreatology undergoes continuous evolution, the 43rd Annual Meeting of the German Pancreas Club presents an opportunity for professionals to engage and discuss these changes within a familiar interdisciplinary environment. Attendees will participate in lectures, poster sessions, a Science Slam, the scientist's toolbox, the pancreas board, and satellite symposia. Workshops are designed to delve into foundational breakthroughs in basic science, specifically focusing on pancreatic cancer, interventional endoscopy, and robotic surgery. Furthermore, young clinical investigators will be offered a basic course in accordance with CTR standards.

The event will address the pressing challenges in European cancer care and discuss key priorities and effective strategies for the future. The summit emphasizes collaborative efforts to enhance cancer care in Europe. Co-chaired by Winette van der Graaf and Kathy Oliver, the program promises to be a comprehensive exploration of the present and future of cancer care in the region.

The "Uncertainty meets Explainability | Workshop and Tutorial" will take place during the 2023 European Conference on Machine Learning. This workshop brings together researchers working at the intersection of ML and natural science and engineering. The technical work presented aligns with RELEVIUM's objectives. 🔍 ML systems in healthcare and finance require accurate predictions and understandable explanations. Combining ·explainability and uncertainty creates reliable AI systems. Exciting innovations include making probabilistic models more interpretable and quantifying the uncertainty in explanations.